Molecular Therapy-Nucleic Acids

Journal Metrics
(Based on the publications from the last 4 years)
(from 2020-12-01 to roughly 2024-12-01)
Number of papers1412
H4-Index49
TQCC16
Average citations11.555
Median citations6
Impact Factor6.500 (based on Web of Science 2023)

(API-Link)

Categories & Ranks
Metric:
(Based on the publications from the last 4 years)
Most cited by this journal
(Based on citations to the other journals in the most recent 30 papers in this journal, at least if metadata about citations were available; last updated 2023-01-08)
Impactful Papers
(Based on publications since 2023; last updated 2024-07-10)
Altmetric Attention Score: 319
Novel hybrid silicon-lipid nanoparticles designed for treating genetic bone diseases efficiently deliver CLCN7G215R-siRNA and cure a preclinical model
Molecular Therapy-Nucleic Acids 2023-08-24
Altmetric Attention Score: 293
Exon 44 skipping in Duchenne muscular dystrophy: NS-089/NCNP-02, a dual-targeting antisense oligonucleotide
Molecular Therapy-Nucleic Acids 2023-09-23
Altmetric Attention Score: 126
Change of intracellular calcium level causes acute neurotoxicity by antisense oligonucleotides via CSF route
Molecular Therapy-Nucleic Acids 2023-03-10
Altmetric Attention Score: 99
Strategic self-limiting production of infectious HIV particles by CRISPR in permissive cells
Molecular Therapy-Nucleic Acids 2023-06-27
Altmetric Attention Score: 98
Topical Application of a CCL22-binding Aptamer Suppresses Contact Allergy
Molecular Therapy-Nucleic Acids 2024-06-20
Ad
0.088387966156006